is essential. Educating patients about the importance of smoking cessation is critical. The quality of life of most patients is poor, marked by significant respiratory distress with minimal physical activity.[16][18] Interstitial lung disease is best addressed by an interprofessional team that includes the patient's primary care doctor, a pulmonologist, nursing staff, and pharmacists, as well as pulmonary function techs and respiratory therapists, to provide optimal patient diagnosis and care. [Level V] ## Review Questions - [Access free multiple choice questions on this topic.](https://www.statpearls.com/account/trialuserreg/?articleid=23648&utm_source=pubmed&utm_campaign=reviews&utm_content=23648) - [Click here for a simplified version.](https://mdsearchlight.com/lung-disease-respiratory-health/interstitial-lung-disease/?utm_source=pubmedlink&utm_campaign=MDS&utm_content=23648) - [Comment on this article.](https://www.statpearls.com/articlelibrary/commentarticle/23648/?utm_source=pubmed&utm_campaign=comments&utm_content=23648) [![Systemic AL Amyloidosis, Pathology, Diffuse Bilateral interstitial lung disease, X-ray, scarring Contributed by Desport et al](/books/NBK541084/bin/AL__Amyloidosis__2E.gif)](/books/NBK541084/figure/article-23648.image.f1/?report=objectonly "Figure") #### [Figure](/books/NBK541084/figure/article-23648.image.f1/?report=objectonly) Systemic AL Amyloidosis, Pathology, Diffuse Bilateral interstitial lung disease, X-ray, scarring Contributed by Desport et al.; BioMed Central (CC By 2.0) http://creativecommons.org/licenses/by/2.0 ## References 1. Rivera-Ortega P, Molina-Molina M. Interstitial Lung Diseases in Developing Countries. Ann Glob Health. 2019 Jan 22;85(1) \[[PMC free article: PMC7052338](/pmc/articles/PMC7052338/)\] \[[PubMed: 30741505](https://pubmed.ncbi.nlm.nih.gov/30741505)\] 2. Mikolasch TA, Garthwaite HS, Porter JC. Update in diagnosis and management of interstitial lung disease . Clin Med (Lond). 2017 Apr;17(2):146-153. \[[PMC free article: PMC6297625](/pmc/articles/PMC6297625/)\] \[[PubMed: 28365626](https://pubmed.ncbi.nlm.nih.gov/28365626)\] 3. Luckhardt TR, Müller-Quernheim J, Thannickal VJ. Update in diffuse parenchymal lung disease 2011. Am J Respir Crit Care Med. 2012 Jul 01;186(1):24-9. \[[PMC free article: PMC5448648](/pmc/articles/PMC5448648/)\] \[[PubMed: 22753686](https://pubmed.ncbi.nlm.nih.gov/22753686)\] 4. Mira-Avendano I, Abril A, Burger CD, Dellaripa PF, Fischer A, Gotway MB, Lee AS, Lee JS, Matteson EL, Yi ES, Ryu JH. Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases. Mayo Clin Proc. 2019 Feb;94(2):309-325. \[[PubMed: 30558827](https://pubmed.ncbi.nlm.nih.gov/30558827)\] 5. Kalchiem-Dekel O, Galvin JR, Burke AP, Atamas SP, Todd NW. Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History. J Clin Med. 2018 Nov 24;7(12) \[[PMC free article: PMC6306719](/pmc/articles/PMC6306719/)\] \[[PubMed: 30477216](https://pubmed.ncbi.nlm.nih.gov/30477216)\] 6. Schwaiblmair M, Behr W, Haeckel T, Märkl B, Foerg W, Berghaus T. Drug induced interstitial lung disease. Open Respir Med J. 2012;6:63-74. \[[PMC free article: PMC3415629](/pmc/articles/PMC3415629/)\] \[[PubMed: 22896776](https://pubmed.ncbi.nlm.nih.gov/22896776)\] 7. Skeoch S, Weatherley N, Swift AJ, Oldroyd A, Johns C, Hayton C, Giollo A, Wild JM, Waterton JC, Buch M, Linton K, Bruce IN, Leonard C, Bianchi S, Chaudhuri N. Drug-Induced Interstitial Lung Disease: A Systematic Review. J Clin Med. 2018 Oct 15;7(10) \[[PMC free article: PMC6209877](/pmc/articles/PMC6209877/)\] \[[PubMed: 30326612](https://pubmed.ncbi.nlm.nih.gov/30326612)\] 8. Capron F. [New classification of interstitial lung disease]. Rev Pneumol Clin. 2005 Jun;61(3):133-40. \[[PubMed: 16142185](https://pubmed.ncbi.nlm.nih.gov/16142185)\] 9. Raghu G, Nyberg